Acquired Gene or Chromosome Alterations – Pipeline Products by Stage of Development 19
Acquired Gene or Chromosome Alterations – Pipeline Products by Territory 20
Acquired Gene or Chromosome Alterations – Pipeline Products by Regulatory Path 21
Acquired Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date 22
Acquired Gene or Chromosome Alterations – Ongoing Clinical Trials 23
Acquired Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development 24
Acquired Gene or Chromosome Alterations – Pipeline Products by Stage of Development 28
Abital Pharma Pipelines Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
Diagnostic Assay – Parkinson’s Disease – Product Status 33
Diagnostic Assay – Parkinson’s Disease – Product Description 33
Admera Health LLC Pipeline Products & Ongoing Clinical Trials Overview 34
Diagnostic Test – Prostate Cancer – Product Status 34
Diagnostic Test – Prostate Cancer – Product Description 34
OncoGxOne Plus – Product Status 35
OncoGxOne Plus – Product Description 35
Pan-Cancer Test – Product Status 35
Pan-Cancer Test – Product Description 36
Agena Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 37
MassARRAY System – Companion Diagnostic Assay – Product Status 37
MassARRAY System – Companion Diagnostic Assay – Product Description 37
Aix-Marseille University Pipeline Products & Ongoing Clinical Trials Overview 38
Companion Diagnostic Assay – T-Cell Acute Lymphoblastic Leukemia – Product Status 38
Companion Diagnostic Assay – T-Cell Acute Lymphoblastic Leukemia – Product Description 38
Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 39
Molecular Assay – Neoplasias and Solid Tumors – Product Status 39
Molecular Assay – Neoplasias and Solid Tumors – Product Description 39
Apteryx Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 40
Oral Cancer Progression – Risk Assessment Test – Product Status 40
Oral Cancer Progression – Risk Assessment Test – Product Description 40
Baruch S. Blumberg Institute Pipeline Products & Ongoing Clinical Trials Overview 41
Cell-Free DNA Assay – Product Status 41
Cell-Free DNA Assay – Product Description 41
Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 42
Diagnostic Assay Assay – Ovarian Cancer – Product Status 42
Diagnostic Assay Assay – Ovarian Cancer – Product Description 42
Noninvasive Diagnostic Test – Colorectal Cancer – Product Status 43
Noninvasive Diagnostic Test – Colorectal Cancer – Product Description 43
bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview 44
BRAF – Breast Cancer Diagnostic Kit – Product Status 44
BRAF – Breast Cancer Diagnostic Kit – Product Description 44
Biotype Innovation GmbH Pipeline Products & Ongoing Clinical Trials Overview 45
Modaplex KRAS Mutation Analysis Kit – Product Status 45
Modaplex KRAS Mutation Analysis Kit – Product Description 45
Modaplex NRAS Mutation Analysis Kit – Product Status 46
Modaplex NRAS Mutation Analysis Kit – Product Description 46
Blondin Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 47
FACT Assay – Metastatic Colon Cancer – Product Status 47
FACT Assay – Metastatic Colon Cancer – Product Description 47
FACT Assay – Metastatic Non-small Cell Lung Cancer – Product Status 48
FACT Assay – Metastatic Non-small Cell Lung Cancer – Product Description 48
FACT Assay – Triple Negative Breast Cancer – Product Status 48
FACT Assay – Triple Negative Breast Cancer – Product Description 49
Cardiff Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Diagnostic Assay – HBV – Product Status 50
Diagnostic Assay – HBV – Product Description 50
Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview 51
Urine Based Screening Test – Cervical Cancer – Product Status 51
Urine Based Screening Test – Cervical Cancer – Product Description 51
Children’s Hospital Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 52
Neuroblastoma Biomarker Assay – Product Status 52
Neuroblastoma Biomarker Assay – Product Description 52
Children’s Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview 53
Diagnostic Assay – Epithelial Tumors – Product Status 53
Diagnostic Assay – Epithelial Tumors – Product Description 53
China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54
FISH Diagnostic Test – Lymphoma – Product Status 54
FISH Diagnostic Test – Lymphoma – Product Description 54
Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 55
Companion Diagnostic Test – Colorectal Cancer – Product Status 55
Companion Diagnostic Test – Colorectal Cancer – Product Description 55
Columbia University Pipeline Products & Ongoing Clinical Trials Overview 56
anti-PD-1 Immunotherapy Resistance Prediction Test – Product Status 56
anti-PD-1 Immunotherapy Resistance Prediction Test – Product Description 56
Biomarker Panel Test – Skin Cancer – Product Status 57
Biomarker Panel Test – Skin Cancer – Product Description 57
Diagnostic Test – Multiple Myeloma – Product Status 57
Diagnostic Test – Multiple Myeloma – Product Description 58
Duke University Pipeline Products & Ongoing Clinical Trials Overview 59
Diagnostic Test – Follicular Thyroid Adenoma/Carcinoma – Product Status 59
Diagnostic Test – Follicular Thyroid Adenoma/Carcinoma – Product Description 59
Empire Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 60
Companion Diagnostic Test – Neuroendocrine Prostate Cancer – Product Status 60
Companion Diagnostic Test – Neuroendocrine Prostate Cancer – Product Description 60
Fred Hutchinson Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 61
ATP7A Gene-Based Immuno-MRM Assay – Product Status 61
ATP7A Gene-Based Immuno-MRM Assay – Product Description 62
BARD1 Gene-Based Immuno-MRM assay – Product Status 62
BARD1 Gene-Based Immuno-MRM assay – Product Description 62
BCL2 Gene-Based Immuno-MRM assay – Product Status 63
BCL2 Gene-Based Immuno-MRM assay – Product Description 63
BCL2L1 Gene-Based Immuno-MRM Assay – Product Status 63
BCL2L1 Gene-Based Immuno-MRM Assay – Product Description 64
C20orf30 Gene Based IMAC MRM Assay – Cancer – Product Status 64
C20orf30 Gene Based IMAC MRM Assay – Cancer – Product Description 64
Diagnostic Test – Oral Cancer – Product Status 65
Diagnostic Test – Oral Cancer – Product Description 65
ERCC5 Gene-Based Immuno-MRM Assay – Product Status 65
ERCC5 Gene-Based Immuno-MRM Assay – Product Description 66
MAD2L2 Gene-Based Immuno-MRM Assay – Product Status 66
MAD2L2 Gene-Based Immuno-MRM Assay – Product Description 66
MYBBP1A Gene Based IMAC MRM Assay – Cancer – Product Status 67
MYBBP1A Gene Based IMAC MRM Assay – Cancer – Product Description 67
MYO9B Gene Based IMAC MRM Assay – Cancer – Product Status 67
MYO9B Gene Based IMAC MRM Assay – Cancer – Product Description 67
NBEAL2 Gene Based IMAC MRM Assay – Cancer – Product Status 68
NBEAL2 Gene Based IMAC MRM Assay – Cancer – Product Description 68
NCL Gene Based IMAC MRM Assay – Cancer – Product Status 68
NCL Gene Based IMAC MRM Assay – Cancer – Product Description 68
NFATC1 Gene Based IMAC MRM Assay – Cancer – Product Status 69
NFATC1 Gene Based IMAC MRM Assay – Cancer – Product Description 69
NSUN2 Gene Based IMAC MRM Assay – Cancer – Product Status 69
NSUN2 Gene Based IMAC MRM Assay – Cancer – Product Description 69
NUFIP2 Gene Based IMAC MRM Assay – Cancer – Product Status 70
NUFIP2 Gene Based IMAC MRM Assay – Cancer – Product Description 70
NUMA1 Gene Based IMAC MRM Assay – Cancer – Product Status 70
NUMA1 Gene Based IMAC MRM Assay – Cancer – Product Description 70
NUP107 Gene Based IMAC MRM Assay – Cancer – Product Status 71
NUP107 Gene Based IMAC MRM Assay – Cancer – Product Description 71
French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 72
Biomarker Based Assay – Pancreatic Cancer – Product Status 72
Biomarker Based Assay – Pancreatic Cancer – Product Description 72
Garvan Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 73
Diagnostic Test – Blood Cancer – Product Status 73
Diagnostic Test – Blood Cancer – Product Description 73
Diagnostic Test- Solid Tumors – Product Status 74
Diagnostic Test- Solid Tumors – Product Description 74
Gencurix Inc Pipeline Products & Ongoing Clinical Trials Overview 75
GenesWell CDx CCT – Product Status 75
GenesWell CDx CCT – Product Description 75
Genetag Technology, Inc Pipeline Products & Ongoing Clinical Trials Overview 76
Blood-Based Assay – Product Status 76
Blood-Based Assay – Product Description 76
DDS Probe – HBV/HCV – Product Status 77
DDS Probe – HBV/HCV – Product Description 77
Genomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview 78
Diagnostic Test – Non Small Cell Lung Cancer – Product Status 78
Diagnostic Test – Non Small Cell Lung Cancer – Product Description 78
Oncotype SEQ – Tissue Mutation Panel – Product Status 79
Oncotype SEQ – Tissue Mutation Panel – Product Description 79
GenomicTree Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
AccuraTect EGFR – Product Status 80
AccuraTect EGFR – Product Description 80
German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 81
BCAT1 Based Diagnosis Assay – Brain Tumor – Product Status 81
BCAT1 Based Diagnosis Assay – Brain Tumor – Product Description 81
Prognostic Assay – Bladder Cancer – Product Status 82
Prognostic Assay – Bladder Cancer – Product Description 82
H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 83
Biomarker Assay – Programmed Death Protein-1 Blockade Immunotherapy – Product Status 83
Biomarker Assay – Programmed Death Protein-1 Blockade Immunotherapy – Product Description 84
Biomarker Based Diagnostic Assay – CTLA-4 Blockade Immunotherapy – Product Status 84
Biomarker Based Diagnostic Assay – CTLA-4 Blockade Immunotherapy – Product Description 84
Companion Diagnostic – Immunotherapy Response Prediction – Product Status 85
Companion Diagnostic – Immunotherapy Response Prediction – Product Description 85
CREB (cAMP Response Element-Binding Protein) Gene Signature Based Assay – Ovarian Cancer – Product Status 85
CREB (cAMP Response Element-Binding Protein) Gene Signature Based Assay – Ovarian Cancer – Product Description 86
Diagnostic Assay – Lung Cancer – Product Status 86
Diagnostic Assay – Lung Cancer – Product Description 86
Diagnostic Assay – Metastatic Melanoma – Product Status 87
Diagnostic Assay – Metastatic Melanoma – Product Description 87
Gene Polymorphism Based Assay – Prostate Cancer Recurrence – Product Status 87
Gene Polymorphism Based Assay – Prostate Cancer Recurrence – Product Description 88
Gene Signature Based Assay – Gliomas – Product Status 88
Gene Signature Based Assay – Gliomas – Product Description 88
Genetic Test – Tumor Sensitivity To Radiation Therapy – Product Status 89
Genetic Test – Tumor Sensitivity To Radiation Therapy – Product Description 89
Immune-related Gene Signature Assay – Cancer – Product Status 89
Immune-related Gene Signature Assay – Cancer – Product Description 90
Immunotherapy Response Prediction Test – Product Status 90
Immunotherapy Response Prediction Test – Product Description 90
NanoString Assay – NSCLC – Product Status 91
NanoString Assay – NSCLC – Product Description 91
NF-KB Based Gene Signature Assay – Cancer – Product Status 91
NF-KB Based Gene Signature Assay – Cancer – Product Description 92
O-Glycan Gene Signature Assay – Ovarian Cancer – Product Status 92
O-Glycan Gene Signature Assay – Ovarian Cancer – Product Description 92
Heali Ltd Pipeline Products & Ongoing Clinical Trials Overview 93
ONCOASSAY Breast – Product Status 93
ONCOASSAY Breast – Product Description 93
Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 94
MicroRNA Based Assay – Osteosarcoma – Product Status 94
MicroRNA Based Assay – Osteosarcoma – Product Description 94
Heidelberg Pharma AG Pipeline Products & Ongoing Clinical Trials Overview 95
TP53/RNA Companion Diagnostic Assay – Product Status 95
TP53/RNA Companion Diagnostic Assay – Product Description 95
Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 96
Genetic Biomarker – Androgenetic Alopecia – Product Status 96
Genetic Biomarker – Androgenetic Alopecia – Product Description 97
Inform Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 98
HSCT – Product Status 98
HSCT – Product Description 98
Institute of Cancer Research Pipeline Products & Ongoing Clinical Trials Overview 99
Liquid Biopsy Test – Product Status 99
Liquid Biopsy Test – Product Description 99
Saliva Based Test – Prostate Cancer – Product Status 100
Saliva Based Test – Prostate Cancer – Product Description 100
Interpace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 101
Diagnostic Assay – Biliary Cancer – Product Status 101
Diagnostic Assay – Biliary Cancer – Product Description 101
PancraMir – Product Status 102
PancraMir – Product Description 102
PathFinderTG MvP Dx – Product Status 102
PathFinderTG MvP Dx – Product Description 103
iTP Biomedica Corp Pipeline Products & Ongoing Clinical Trials Overview 104
Prognostic Test – Kidney Fibrosis – Product Status 104
Prognostic Test – Kidney Fibrosis – Product Description 104
Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 105
Anti-Cancer Drug Based Assay – Product Status 106
Anti-Cancer Drug Based Assay – Product Description 106
Biomarker Assay – Metastatic Prostate Cancer – Product Status 106
Biomarker Assay – Metastatic Prostate Cancer – Product Description 107
BRCA2 Diagnostic Assay – Product Status 107
BRCA2 Diagnostic Assay – Product Description 107
CpG Hypermethylated Gene Assay – Colorectal Cancer – Product Status 108
CpG Hypermethylated Gene Assay – Colorectal Cancer – Product Description 108
Diagnosis Assay – Esophageal Cancer – Product Status 108
Diagnosis Assay – Esophageal Cancer – Product Description 109
Diagnostic And Prognostic Biomarker Assay – Thyroid Cancer – Product Status 109
Diagnostic And Prognostic Biomarker Assay – Thyroid Cancer – Product Description 109
Diagnostic Assay – ESCC – Product Status 110
Diagnostic Assay – ESCC – Product Description 110
Diagnostic Assay – Sturge-Weber Syndrome – Product Status 110
Diagnostic Assay – Sturge-Weber Syndrome – Product Description 111
Diagnostic Kit – Pancreatic Neuroendrocrine Tumor – Product Status 111
Diagnostic Kit – Pancreatic Neuroendrocrine Tumor – Product Description 111
Diagnostic Test – Brain Cancer – Product Status 112
Diagnostic Test – Brain Cancer – Product Description 112
Epigenetic Diagnostic Assay – Gastric Cancer – Product Status 112
Epigenetic Diagnostic Assay – Gastric Cancer – Product Description 113
Epigenetically Silenced Gene Assay – Colon Cancer – Product Status 113
Epigenetically Silenced Gene Assay – Colon Cancer – Product Description 113
Epigenetically Silenced Gene Assay – Gastric Cancer – Product Status 114
Epigenetically Silenced Gene Assay – Gastric Cancer – Product Description 114
Gene Based Biomarker Assay – Thyroid Cancer – Product Status 114
Gene Based Biomarker Assay – Thyroid Cancer – Product Description 115
GSTP1 Hypermethylation Assay – Product Status 115
GSTP1 Hypermethylation Assay – Product Description 115
HEYL Oncogene Test – Product Status 116
HEYL Oncogene Test – Product Description 116
HOXB13 Biomarker Test – Prostate Cancer – Product Status 116
HOXB13 Biomarker Test – Prostate Cancer – Product Description 117
Methyl-BEAMing Assay – Product Status 117
Methyl-BEAMing Assay – Product Description 117
Molecular Diagnostic Assay – Aggressive Brain Tumor – Product Status 118
Molecular Diagnostic Assay – Aggressive Brain Tumor – Product Description 118
Prognostic Assay – Breast Cancer – Product Status 118
Prognostic Assay – Breast Cancer – Product Description 119
Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 120
Blood-Companion Diagnostic Assay – Glioblastoma – Product Status 120
Blood-Companion Diagnostic Assay – Glioblastoma – Product Description 120
Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 121
Colorectal Cancer Risk Assessment Test – Product Status 121
Colorectal Cancer Risk Assessment Test – Product Description 121
Diagnostic Test – Bladder Cancer – Product Status 122
Diagnostic Test – Bladder Cancer – Product Description 122
Genetic Test – Breast Cancer – Product Status 122
Genetic Test – Breast Cancer – Product Description 123
McGill University Pipeline Products & Ongoing Clinical Trials Overview 124
Diagnostic Test – Glioblastoma – Product Status 124
Diagnostic Test – Glioblastoma – Product Description 124
MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 125
Skin DNA Mitomic Test – Product Status 125
Skin DNA Mitomic Test – Product Description 125
MolecularMD Corp Pipeline Products & Ongoing Clinical Trials Overview 126
Companion Diagnostic Assay – Non-Small Cell Lung Cancer – Product Status 126
Companion Diagnostic Assay – Non-Small Cell Lung Cancer – Product Description 126
FGFR2 Mutation Assay – Product Status 127
FGFR2 Mutation Assay – Product Description 127
IHC Assay – Lung Cancer – Product Status 127
IHC Assay – Lung Cancer – Product Description 127
Myriad International GmbH Pipeline Products & Ongoing Clinical Trials Overview 128
ChemoPredict Test – Product Status 128
ChemoPredict Test – Product Description 128
Nel ASA Pipeline Products & Ongoing Clinical Trials Overview 129
PDtect – Product Status 129
PDtect – Product Description 129
Northern California Institute for Research and Education Pipeline Products & Ongoing Clinical Trials Overview 130
Biomarkers – Kidney Cancer – Product Status 130
Biomarkers – Kidney Cancer – Product Description 130
NucleoBio Inc Pipeline Products & Ongoing Clinical Trials Overview 131
Prostac – Product Status 131
Prostac – Product Description 131
Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 132
Diagnostic Test – Lung Cancer – Product Status 132
Diagnostic Test – Lung Cancer – Product Description 132
OmicsWay Corp Pipeline Products & Ongoing Clinical Trials Overview 133
Oncobox:Sorafenib Test – Product Status 133
Oncobox:Sorafenib Test – Product Description 133
Oxford Biodynamics Plc Pipeline Products & Ongoing Clinical Trials Overview 134
EpiSwitch Nasopharyngeal Cancer Test – Product Status 134
EpiSwitch Nasopharyngeal Cancer Test – Product Description 134
EpiSwitch Prostate Cancer Prognostic Assay – Product Status 135
EpiSwitch Prostate Cancer Prognostic Assay – Product Description 135
Oxford Cancer Biomarkers Ltd Pipeline Products & Ongoing Clinical Trials Overview 136
ColoPredict – Product Status 136
ColoPredict – Product Description 136
Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 137
Lipid Nanoprobe Test – Product Status 137
Lipid Nanoprobe Test – Product Description 137
Princess Margaret Cancer Centre Pipeline Products & Ongoing Clinical Trials Overview 138
Screening Test – AML – Product Status 138
Screening Test – AML – Product Description 138
QuantuMDx Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 139
Q-POC – EGFR NSCLC Assay – Product Status 139
Q-POC – EGFR NSCLC Assay – Product Description 139
Queen’s University Belfast Pipeline Products & Ongoing Clinical Trials Overview 140
Blood Based Assay – Cancer – Product Status 140
Blood Based Assay – Cancer – Product Description 140
Rosetta Genomics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 141
RosettaGX Reveal – Second Version – Product Status 141
RosettaGX Reveal – Second Version – Product Description 141
Stanford University Pipeline Products & Ongoing Clinical Trials Overview 142
Biomarker Panel – Bladder Cancer – Product Status 142
Biomarker Panel – Bladder Cancer – Product Description 142
Screening Test – Post-Transplant Lymphoproliferative Disease – Product Status 143
Screening Test – Post-Transplant Lymphoproliferative Disease – Product Description 143
Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 144
Diagnostic Test – Colorectal Cancer – Product Status 144
Diagnostic Test – Colorectal Cancer – Product Description 144
Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 145
BRCA 1 & BRCA 2 Test Kit – Product Status 145
BRCA 1 & BRCA 2 Test Kit – Product Description 145
EGFR Mutational Analysis Kit – Product Status 146
EGFR Mutational Analysis Kit – Product Description 146
JAK2 Mutational Analysis Test Kit – Product Status 146
JAK2 Mutational Analysis Test Kit – Product Description 146
Telo Genomics Corp Pipeline Products & Ongoing Clinical Trials Overview 147
3D Telo-BC Test – Product Status 147
3D Telo-BC Test – Product Description 148
3D Telo-CE Test – Product Status 148
3D Telo-CE Test – Product Description 148
3D Telo-HL Test – Product Status 149
3D Telo-HL Test – Product Description 149
3D Telo-MM Test – Product Status 149
3D Telo-MM Test – Product Description 150
3D Telo-TC Test – Product Status 150
3D Telo-TC Test – Product Description 150
The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 151
Diagnostic Assay – Cataract – Product Status 151
Diagnostic Assay – Cataract – Product Description 151
Diagnostic Assay – Gastric Cancer – Product Status 152
Diagnostic Assay – Gastric Cancer – Product Description 152
Human Hepatocellular Carcinoma Diagnostic Kit – Product Status 152
Human Hepatocellular Carcinoma Diagnostic Kit – Product Description 152
The University of New South Wales press Limited Pipeline Products & Ongoing Clinical Trials Overview 153
Gold-Plated Nanoparticle Device – Cancer – Product Status 153
Gold-Plated Nanoparticle Device – Cancer – Product Description 153
The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 154
ctDNA Test – Ovarian Cancer – Product Status 154
ctDNA Test – Ovarian Cancer – Product Description 154
ctDNA Test – Pancreatic Cancer – Product Status 155
ctDNA Test – Pancreatic Cancer – Product Description 155
The Walter and Eliza Hall Institute of Medical Research – Ongoing Clinical Trials Overview 156
ctDNA Test – Ovarian Cancer – A Study to Evaluate the Use of Circulating Tumour DNA to Guide Adjuvant Chemotherapy on Recurrence-free Survival in Patients with Stage II Colon or Rectal Cancer 157
TheraDiag SA Pipeline Products & Ongoing Clinical Trials Overview 158
microRNA Prognostic Test – Ovarian Cancer – Product Status 158
microRNA Prognostic Test – Ovarian Cancer – Product Description 158
microRNA Theranostic Test – Autoimmune Disease – Product Status 159
microRNA Theranostic Test – Autoimmune Disease – Product Description 159
microRNA Theranostic Test – Colorectal Cancer – Product Status 159
microRNA Theranostic Test – Colorectal Cancer – Product Description 160
Tissue Messenger RNA Based Test – Rectal Cancer – Product Status 160
Tissue Messenger RNA Based Test – Rectal Cancer – Product Description 160
TheraDiag SA – Ongoing Clinical Trials Overview 161
microRNA Theranostic Test – Colorectal Cancer – microRNA Signature Predicting a Subject’s Therapeutic Response in Locally Advanced Rectal Cancer 162
Therawis Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 163
EpiRespond-TN – Product Status 163
EpiRespond-TN – Product Description 163
Thrive Earlier Detection Corp Pipeline Products & Ongoing Clinical Trials Overview 164
UroSeqS – Product Status 164
UroSeqS – Product Description 164
Total Brain Ltd Pipeline Products & Ongoing Clinical Trials Overview 165
ADHD Treatment Test With Cognition Plus Selected Genomics – Product Status 165
ADHD Treatment Test With Cognition Plus Selected Genomics – Product Description 165
Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 166
Lungmark – Product Status 166
Lungmark – Product Description 166
University College London Pipeline Products & Ongoing Clinical Trials Overview 167
Genetic Profile Test – Lung Cancer – Product Status 167
Genetic Profile Test – Lung Cancer – Product Description 167
University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 168
Biomarker Test – Chronic Myelogenous Leukemia (CML) Progression – Product Status 168
Biomarker Test – Chronic Myelogenous Leukemia (CML) Progression – Product Description 168
University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 169
Diagnostic Blood Test – Ovarian Cancer – Product Status 169
Diagnostic Blood Test – Ovarian Cancer – Product Description 169
Genetic Test – Oesophageal Cancer – Product Status 170
Genetic Test – Oesophageal Cancer – Product Description 170
University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 171
MKRN1 Biomarker Assay – Product Status 171
MKRN1 Biomarker Assay – Product Description 171
University of Cologne Pipeline Products & Ongoing Clinical Trials Overview 172
NRG1/CD74 Gene Fusion Test – Lung Cancer – Product Status 172
NRG1/CD74 Gene Fusion Test – Lung Cancer – Product Description 172
University of Copenhagen Pipeline Products & Ongoing Clinical Trials Overview 173
Diagnostic Blood Test – Pancreatic Cancer – Product Status 173
Diagnostic Blood Test – Pancreatic Cancer – Product Description 173
University of Hawaii at Manoa Pipeline Products & Ongoing Clinical Trials Overview 174
Companion Diagnostic Test – Breast Cancer – Product Status 174
Companion Diagnostic Test – Breast Cancer – Product Description 174
University of Montreal Pipeline Products & Ongoing Clinical Trials Overview 175
Genetic Biomarker Test – Ovarian Cancer – Product Status 175
Genetic Biomarker Test – Ovarian Cancer – Product Description 175
Prognostic Tool – Acute Myeloid Leukemia – Product Status 176
Prognostic Tool – Acute Myeloid Leukemia – Product Description 176
University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 177
Diagnostic Test – Lymphoma – Product Status 177
Diagnostic Test – Lymphoma – Product Description 177
University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 178
miR-489 Based Diagnostic Test – Breast Cancer – Product Status 178
miR-489 Based Diagnostic Test – Breast Cancer – Product Description 178
University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 179
Blood Test – Metastatic breast cancer – Product Status 179
Blood Test – Metastatic breast cancer – Product Description 179
Gene Based Test – Colorectal Cancer – Product Status 180
Gene Based Test – Colorectal Cancer – Product Description 180
University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 181
RNA-Nanoprobe – Lung Cancer – Product Status 181
RNA-Nanoprobe – Lung Cancer – Product Description 181
University of Sydney Pipeline Products & Ongoing Clinical Trials Overview 182
PROSPER-2 Genomic Test – Product Status 182
PROSPER-2 Genomic Test – Product Description 182
University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 183
TSG 101 Based Diagnostic Assay – Product Status 183
TSG 101 Based Diagnostic Assay – Product Description 183
University of Washington Pipeline Products & Ongoing Clinical Trials Overview 184
Biomarker Assay – Colon Cancer – Product Status 184
Biomarker Assay – Colon Cancer – Product Description 184
Vyant Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 185
UroGenRA – Bladder – Product Status 185
UroGenRA – Bladder – Product Description 185
Wistar Institute Pipeline Products & Ongoing Clinical Trials Overview 186
29-Gene Signature Based Test – Lung Cancer – Product Status 186
29-Gene Signature Based Test – Lung Cancer – Product Description 186
Yaathum Biotech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 187
Screening-Diagnostic-Prognostic Test – Thalassemia – Product Status 187
Screening-Diagnostic-Prognostic Test – Thalassemia – Product Description 187
Yale University Pipeline Products & Ongoing Clinical Trials Overview 188
Diagnostic Test – Prostate Cancer – Product Status 188
Diagnostic Test – Prostate Cancer – Product Description 188
Glossary 282
